Regulated antigen expression in live recombinant Salmonella enterica serovar Typhimurium strongly affects colonization capabilities and specific CD4+-T-cell responses

Infection and Immunity

Volumn 69, Issue 12, 2001, Pages 7493-7500

  Bumann, D ^a  

^a MAX PLANCK INSTITUTE FOR INFECTION BIOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GREEN FLUORESCENT PROTEIN; OVALBUMIN; SALMONELLOSIS VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN EXPRESSION; ANTIGEN RECOGNITION; ANTIGEN SPECIFICITY; ARTICLE; BACTERIAL COLONIZATION; CELLULAR IMMUNITY; FEMALE; IMMUNE RESPONSE; IMMUNOGENICITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; SALMONELLA ENTERICA; SALMONELLA TYPHIMURIUM; T LYMPHOCYTE;

ANIMALS; ANTIGENS, BACTERIAL; CD4-POSITIVE T-LYMPHOCYTES; FEMALE; GENE EXPRESSION REGULATION, BACTERIAL; GREEN FLUORESCENT PROTEINS; LUMINESCENT PROTEINS; MICE; MICE, INBRED BALB C; MICE, TRANSGENIC; OVALBUMIN; PEYER'S PATCHES; PROMOTER REGIONS (GENETICS); RECEPTORS, ANTIGEN, T-CELL; RECOMBINANT FUSION PROTEINS; SALMONELLA TYPHIMURIUM; SALMONELLA VACCINES; VACCINES, SYNTHETIC;

EID: 0035189087     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.69.12.7493-7500.2001     Document Type: Article

References (51)

1. Growth rate paradox of Salmonella typhimurium within host macrophages
2. Salmonella typhimurium activates virulence gene transcription within acidified macrophage phagosomes
3. Delivery of the pertactin/P.69 polypeptide of Bordetella pertussis using an attenuated Salmonella typhimurium vaccine strain: Expression levels and immune response
4. Antibody responses to Yersinia pestis F1-antigen expressed in Salmonella typhimurium aroA from in vivo-inducible promoters
5. In vivo visualization of bacterial colonization, antigen expression, and specific T-cell induction following oral administration of live recombinant Salmonella enterica serovar Typhimurium
6. Recombinant live Salmonella spp. for human vaccination against heterologous pathogens
7. Cell-specific proteins synthesized by Salmonella typhimurium
8. Stability, immunogenicity and expression of foreign antigens in bacterial vaccine vectors
9. Use of the nirB promoter to direct the stable expression of heterologous antigens in Salmonella oral vaccine strains: Development of a single-dose oral tetanus vaccine
10. Enhanced immune responses to viral epitopes by combining macrophage-inducible expression with multimeric display on a Salmonella vector
11. 5) and resistant (Ity) BALB/c mice
12. Inoculum composition and Salmonella pathogenicity island 1 regulate M-cell invasion and epithelial destruction by Salmonella typhimurium
13. Identification of a natural T cell epitope presented by Salmonella-infected macrophages and recognized by T cells from orally immunized mice
14. c expressing urease A and B subunits
15. Bacterial virulence gene regulation: An evolutionary perspective
16. Levels of expression and immunogenicity of attenuated Salmonella enterica serovar Typhimurium strains expressing Escherichia coli mutant heat-labile enterotoxin
17. Antibody responses against flagellin in mice orally immunized with attenuated Salmonella vaccine strains
18. Comparison of the abilities of different attenuated Salmonella typhimurium strains to elicit humoral immune responses against a heterologous antigen
19. Use of in vivo-regulated promoters to deliver antigens from attenuated Salmonella enterica var
20. Regulatory circuits involved with pH-regulated gene expression in Salmonella typhimurium
21. 2+ as an extracellular signal: Environmental regulation of Salmonella virulence
22. Immunogenicity of a Salmonella typhi CVD 908 candidate vaccine strain expressing the major surface protein gp63 of Leishmania mexicana mexicana
23. In vitro binding of the Salmonella dublin virulence plasmid regulatory protein SpvR to the promoter regions of spvA and spvR
24. The pleiotropic two-component regulatory system PhoP-PhoQ
25. The major histocompatibility complex-restricted antigen receptor on T cells. I. Isolation with a monoclonal antibody
26. Macrophage -inducible expression of a model antigen in Salmonella typhimurium enhances immunogenicity
27. Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccines
28. The in vivo division and death rates of Salmonella typhimurium in the spleens of naturally resistant and susceptible mice measured by the superinfecting phage technique of Meynell
29. Novel approaches to monitor bacterial gene expression in infected tissue and host
30. Attenuated Salmonella typhi and Shigella as live oral vaccines and as live vectors
31. Unravelling the mysteries of virulence gene regulation in Salmonella typhimurium
32. Use of the stationary phase inducible promoters, spv and dps, to drive heterologous antigen expression in Salmonella vaccine strains
33. + T cell responses during natural infection with Salmonella typhimurium
34. Vaccine efficacy of Salmonella strains expressing glycoprotein 63 with different promoters
35. Modulation of host immune responses stimulated by Salmonella vaccine carrier strains by using different promoters to drive the expression of the recombinant antigen
36. lo thymocytes in vivo
37. Novel use of anaerobically induced promoter, dmsA, for controlled expression of fragment C of tetanus toxin in live attenuated Salmonella enterica serovar Typhi strain CVD 908-htrA
38. Use of adoptive transfer of T-cell-antigen-receptor-transgenic T cell for the study of T-cell activation in vivo
39. Oral vaccination against tetanus: Comparison of the immunogenicities of Salmonella strains expressing fragment C from the nirB and htrA promoters
40. Confrontation between intracellular bacteria and the immune system
41. Live attenuated Salmonella: A paradigm of mucosal vaccines
42. Transcriptional autoregulation of the Salmonella typhimurium phoPQ operon
43. Construction of stable LamB-Shiga toxin B subunit hybrids: Analysis of expression in Salmonella typhimurium aroA strains and stimulation of B subunit-specific mucosal and serum antibody responses
44. Safety and immune responses to attenuated Salmonella enterica serovar Typhi oral live vector vaccines expressing tetanus toxin fragment C
45. Safety of live oral Salmonella typhi vaccine strains with deletions in htrA and aroC aroD and immune response in humans
46. Phase 2 clinical trial of attenuated Salmonella enterica serovar Typhi oral live vector vaccine CVD 908-htrA in U.S. volunteers
47. Fluorescence-based isolation of bacterial genes expressed within host cells
48. Constitutive expression of the Vi polysaccharide capsular antigen in attenuated Salmonella enterica serovar Typhi oral vaccine strain CVD 909
49. Parameters that influence the efficiency of processing antigenic epitopes expressed in Salmonella typhimurium
50. The phoP locus influences processing and presentation of Salmonella typhimurium antigens by activated macrophages
51. )